Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 161-172

  Talmadge, J E ^a   Reed, E ^a   Ino, K ^a   Kessinger, A ^a   Kuszynski, C ^a   Heimann, D ^a   Varney, M ^a   Jackson, J ^a   Vose, J M ^a   Bierman, P J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

BMT; Immunity; NHL; NK cell F; PSCT; T cell

Indexed keywords

CARMUSTINE; CD14 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; EFFECTOR CELL; FEMALE; HELPER CELL; HUMAN; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MITOGENESIS; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 17144456465     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700626     Document Type: Article

References (59)

1. Hryniuk W, Levine MN. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol 1986; 4: 1162-1170.
2. Tannock IF, Boyd NF, DeBoer G et al. A randomized trial of two dose levels of cyclophosphamide, methotraxate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 1988; 6: 1377-1387.
3. Bezwada WR, Seymour L, Dansey RD. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 1995; 13: 2483-2489.
4. Liberti G, Pearce R, Taghipour G et al. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Ann Oncol 1994; 5: 5151-5153.
5. Kessinger A. Is blood or bone marrow better? Stem Cells 1993; 11: 290-295.
6. Ager S, Scott MA, Mahendra P et al. Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow transplantation. Bone Marrow Transplant 1995; 16: 79-83.
7. Williams SF, Zimmerman T, Grad G, Mick R. Source of stem cell rescue: bone marrow versus peripheral blood progenitors. J Hematother 1993; 2: 521-523.
8. To LB, Roberts M, Haylock D. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
9. Vose JM, Anderson JR, Kessinger A et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1846-1851.
10. Freedman AS, Nadler LM. Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation? J Clin Oncol 1993; 11: 1841-1843.
11. Janssen WE, Smilee RC, Elfenbein GJ. A prospective randomized trial comparing blood-and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 1995; 4: 139-140.
12. Rapoport AP, Rowe JM, Kouides PA et al. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. J Clin Oncol 1993; 11: 2351-2361.
13. Meyers SE, Mick R, Williams SF. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant. Bone Marrow Transplant 1994; 13: 449-454.
14. Talmadge JE, Reed EC, Kessinger A et al. Immunologic attributes to cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
15. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
16. Roberts MM, To LB. Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
17. Kiesel S, Pezzutto A, Moldenhaur G et al. B-cell proliferative and differentiative response after autologous peripheral blood stem cell or bone marrow transplantation. Blood 1988; 72: 672-678.
18. Guillaume T, Sekhavat M, Rubinstein DB et al. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res 1994; 54: 3800-3807.
19. Vaughan WP, Kris E, Vose J et al. Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma. J Clin Oncol 1995; 13: 1089-1095.
20. Badger AM, King AG, Talmadge JE et al. Induction of non-specific suppressor cells by a novel azaspirane, SK&F 105685, an immunomodulatory compound with therapeutic activity in animal models of autoimmune disease. J Autoimmun 1990; 3: 485-500.
21. Badger AM, Mirabelli CK, DiMartino M. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug. Immunopharmacol 1985; 10: 201-207.
22. Mills KC, Gross TG, Varney ML et al. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Bone Marrow Transplant 1996; 18: 1-6.
23. Wiener D, Shah S, Malone J et al. Multiparametric analysis of peripheral blood in the normal pediatric population by flow cytometry. J Clin Lab Anal 1990; 4: 175-179.
24. Schrappe-Bacher M, Salzberger B, Fatkenheuer G et al. T-lymphocyte subsets in the duodenal lamina propria of patients infected with the human immunodeficiency virus type 1 and influence of high-dose immunoglobulin therapy. J Acquir Immune Defic Syn 1990; 3: 238-243.
25. Schmitz-Wolf IG, Dejbakhsh-Jones S, Ginzton N et al. T-cell subsets and suppressor cells in human bone marrow. Blood 1992; 80: 3242-3250.
26. Atkinson K, Hansen JA, Storb R et al. T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer cytotoxic-suppressor subsets. Blood 1982; 59: 1292-1298.
27. Miller RA, Daley J, Ghalie R, Kaizer H. Clonal analysis of T-cell deficiencies in autotransplant recipients. Blood 1991; 77: 1845-1850.
28. Olsen GA, Gockerman JP, Bast RC Jr et al. Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support. Transplantation 1988; 46: 57-60.
29. Gratama JW, Naipal A, Oljans P et al. T-lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4 and T8 T-lymphocytes correlate with the occurenee of acute GVHD. Blood 1984; 63:1416-1423.
30. Armitage RJ, Goldstone AH, Richards JD, Cawley JC. Lymphocyte function after autologous hone marrow transplantation (BMT): a comparison with patients treated with allogeneic BMT and with chemotherapy only. Br J Haematol 1986; 63: 637-647.
31. Lum LG, Joshi ID, Smith MR et al. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact. Bone Marrow Transplant 1994; 13: 187-195.
32. + dual-positive T cell reminiscent of ontogeny. J Hematother 1992; 1: 303-316.
33. Villers D, Milpied N, Gaschet J et al. Alteration of the T cell repertoire after bone marrow transplantation. Bone Marrow Transplant 1994; 13: 19-26.
34. Matsue K, Lum LG, Witherspoon RP, Storb R. Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. Blood 1987; 69: 308-315.
35. Franceschini F, Gale RP. Progress in bone marrow transplantation. In: Gale RP, Champlin RE (eds). UCLA Symposia on Molecular and Cellular Biology. Allan R Liss: New York, 1987, pp 607-622.
36. Saxon A. Progress in bone marrow transplantation. In: Gale RP, Champlin RE (eds). UCLA Symposia on Molecular and Cellular Biology. Allan R Liss: New York, 1987, pp 623-633.
37. Lum LG. Immune recovery after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 659-675.
38. + T cell subsets in the allogeneic bone marrow transplant recipient. Cancer Immunol Immunother 1995; 41: 104-110.
39. Gaschet J, Denis C, Milpied N et al. Alternations of T cell repertoire after bone marrow transplantation: characterization of over-represented subsets. Bone Marrow Transplant 1995; 19: 427-435.
40. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413-425.
41. Ault KA, Antin JH, Ginsburg D et al. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161: 1483-1502.
42. Niederwieser D, Gastl G, Rumpold H et al. Rapid reappearance of large granular lymphocytes with concomitant reconstitution of natural killer activity after human bone marrow transplantation. Br J Haematol 1987; 65: 301-305.
43. Hokland M, Jacobsen J, Ellegaard J, Hokland P. Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection. Transplantation 1988; 45: 1080-1084.
44. Bengtsson M, Totterman TH, Smedmyr B et al. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 1989; 3: 68-75.
45. Atkinson K, Biggs JC, Downs K et al. GM-CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes. Aust NZ J Med 1991; 21: 686-692.
46. Leino L, Lilius EM, Nikoskelainen J et al. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic hone marrow transplantation. Bone Marrow Transplant 1991; 8: 339-344.
47. DeWitte T, Gratwohl A, VanDerLely N et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depeleted bone marrow transplantation. Blood 1992; 79: 1359-1365.
48. Ericson SG, Colby E, Welch L, Ball ED. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow. Bone Marrow Transplant 1992; 9: 129-137.
49. Bortin MM, Truitt RL, Rimm AA, Bach FM. Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature 1979; 281: 490-491.
50. DeBruin HG, Astaldi A, Leupers T et al. T lymphocyte characteristics in bone marrow-transplanted patients. J Immunol 1981; 127: 244-251.
51. Friedrich W, O'Reilly RJ, Koziner B et al. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood 1982; 59: 696-701.
52. Schroff RW, Gale RP, Fahey JL. Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol 1982; 129: 1926-1930.
53. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
54. Sviland L, Pearson SD, Green MS et al. Immunopathology of early graft-versus-host disease - a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients. Transplantation 1991; 52: 1029-1036.
55. Ashihara E, Shimazaki C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two color cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
56. Scambia G, Panici PB, Pierelli L et al. Immunological reconstitution after high dose chemotherapy and autologous blood stem cell transplantation for advanced ovarian cancer. Eur J Cancer 1993; 29: 1518-1522.
57. Ho AD, Maruyama M, Maghazachi A et al. Soluble CD4, soluble CD8, soluble CD25, lymphopoietic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation. Blood 1994; 84: 3550-3557.
58. Neubauer MA, Benyunes MC, Thompson JA et al. Lymphokine-activated killer (LAK) precusor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1994; 13: 311-316.
59. Kiesel S, Pezzutto A, Korbling M et al. Autologous peripheral blood stem cell transplantation: analysis of autograted cells and lymphocyte recovery. Transplant Proc 1989; 21: 3084-3088.